Cargando…
Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds
Extracellular matrix (ECM) is a complex structure composed of bioactive molecules representative of the local tissue microenvironment. Decellularized ECM biomaterials harness these biomolecules for regenerative medicine applications. One potential therapeutic application is the use of vocal fold (VF...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416610/ https://www.ncbi.nlm.nih.gov/pubmed/34731852 http://dx.doi.org/10.1088/1748-605X/ac361f |
_version_ | 1784776520547434496 |
---|---|
author | Mora-Navarro, Camilo Garcia, Mario E Sarker, Prottasha Ozpinar, Emily W Enders, Jeffrey R Khan, Saad Branski, Ryan C Freytes, Donald O |
author_facet | Mora-Navarro, Camilo Garcia, Mario E Sarker, Prottasha Ozpinar, Emily W Enders, Jeffrey R Khan, Saad Branski, Ryan C Freytes, Donald O |
author_sort | Mora-Navarro, Camilo |
collection | PubMed |
description | Extracellular matrix (ECM) is a complex structure composed of bioactive molecules representative of the local tissue microenvironment. Decellularized ECM biomaterials harness these biomolecules for regenerative medicine applications. One potential therapeutic application is the use of vocal fold (VF) specific ECM to restore the VFs after injury. ECM scaffolds are derived through a process of decellularization, which aims to remove unwanted immunogenic biomolecules (e.g. DNA) while preserving the composition of the ECM. The effectiveness of the decellularization is typically assessed at the end by quantifying ECM attributes such as final dsDNA content. However, batch-to-batch variability in ECM manufacturing remains a significant challenge for the standardization, cost-effectiveness, and scale-up process. The limited number of tools available for in-process control heavily restricts the uncovering of the correlations between decellularization process parameters and ECM attributes. In this study, we developed a technique applicable to both the classical batch method and semi-continuous decellularization systems to trace the decellularization of two laryngeal tissues in real-time. We hypothesize that monitoring the bioreactor’s effluent absorbance at 260 nm as a function of time will provide a representative DNA release profile from the tissue and thus allow for process optimization. The DNA release profiles were obtained for laryngeal tissues and were successfully used to optimize the derivation of VF lamina propria-ECM (auVF-ECM) hydrogels. This hydrogel had comparable rheological properties to commonly used biomaterials to treat VF injuries. Also, the auVF-ECM hydrogel promoted the down-regulation of CCR7 by THP-1 macrophages upon lipopolysaccharide stimulation in vitro suggesting some anti-inflammatory properties. The results show that absorbance profiles are a good representation of DNA removal during the decellularization process thus providing an important tool to optimize future protocols. |
format | Online Article Text |
id | pubmed-9416610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-94166102022-08-26 Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds Mora-Navarro, Camilo Garcia, Mario E Sarker, Prottasha Ozpinar, Emily W Enders, Jeffrey R Khan, Saad Branski, Ryan C Freytes, Donald O Biomed Mater Article Extracellular matrix (ECM) is a complex structure composed of bioactive molecules representative of the local tissue microenvironment. Decellularized ECM biomaterials harness these biomolecules for regenerative medicine applications. One potential therapeutic application is the use of vocal fold (VF) specific ECM to restore the VFs after injury. ECM scaffolds are derived through a process of decellularization, which aims to remove unwanted immunogenic biomolecules (e.g. DNA) while preserving the composition of the ECM. The effectiveness of the decellularization is typically assessed at the end by quantifying ECM attributes such as final dsDNA content. However, batch-to-batch variability in ECM manufacturing remains a significant challenge for the standardization, cost-effectiveness, and scale-up process. The limited number of tools available for in-process control heavily restricts the uncovering of the correlations between decellularization process parameters and ECM attributes. In this study, we developed a technique applicable to both the classical batch method and semi-continuous decellularization systems to trace the decellularization of two laryngeal tissues in real-time. We hypothesize that monitoring the bioreactor’s effluent absorbance at 260 nm as a function of time will provide a representative DNA release profile from the tissue and thus allow for process optimization. The DNA release profiles were obtained for laryngeal tissues and were successfully used to optimize the derivation of VF lamina propria-ECM (auVF-ECM) hydrogels. This hydrogel had comparable rheological properties to commonly used biomaterials to treat VF injuries. Also, the auVF-ECM hydrogel promoted the down-regulation of CCR7 by THP-1 macrophages upon lipopolysaccharide stimulation in vitro suggesting some anti-inflammatory properties. The results show that absorbance profiles are a good representation of DNA removal during the decellularization process thus providing an important tool to optimize future protocols. 2021-11-26 /pmc/articles/PMC9416610/ /pubmed/34731852 http://dx.doi.org/10.1088/1748-605X/ac361f Text en https://creativecommons.org/licenses/by/4.0/Original content from this work may be used under the terms of the Creative Commons Attribution 4.0 licence. |
spellingShingle | Article Mora-Navarro, Camilo Garcia, Mario E Sarker, Prottasha Ozpinar, Emily W Enders, Jeffrey R Khan, Saad Branski, Ryan C Freytes, Donald O Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds |
title | Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds |
title_full | Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds |
title_fullStr | Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds |
title_full_unstemmed | Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds |
title_short | Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds |
title_sort | monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416610/ https://www.ncbi.nlm.nih.gov/pubmed/34731852 http://dx.doi.org/10.1088/1748-605X/ac361f |
work_keys_str_mv | AT moranavarrocamilo monitoringdecellularizationviaabsorbancespectroscopyduringthederivationofextracellularmatrixscaffolds AT garciamarioe monitoringdecellularizationviaabsorbancespectroscopyduringthederivationofextracellularmatrixscaffolds AT sarkerprottasha monitoringdecellularizationviaabsorbancespectroscopyduringthederivationofextracellularmatrixscaffolds AT ozpinaremilyw monitoringdecellularizationviaabsorbancespectroscopyduringthederivationofextracellularmatrixscaffolds AT endersjeffreyr monitoringdecellularizationviaabsorbancespectroscopyduringthederivationofextracellularmatrixscaffolds AT khansaad monitoringdecellularizationviaabsorbancespectroscopyduringthederivationofextracellularmatrixscaffolds AT branskiryanc monitoringdecellularizationviaabsorbancespectroscopyduringthederivationofextracellularmatrixscaffolds AT freytesdonaldo monitoringdecellularizationviaabsorbancespectroscopyduringthederivationofextracellularmatrixscaffolds |